New cancer injection tested in patients out of options
NCT ID NCT07203898
Summary
This is the first human study of an experimental injection called IPM514 for people with advanced esophageal cancer that has spread or returned after standard treatments. The main goal is to find a safe dose by testing six different strength levels in 36 patients. Researchers will monitor for side effects and see if the treatment shows any early signs of slowing the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.